FDA approves expanded use of Verify system for incontinence therapy

The FDA has granted the Verify Evaluation System approval for three- to seven-day basic evaluations, according to a Med Device Online report.

Advertisement

Basic evaluations are designed to expedite the potential for long-term restoration of bowel or bladder function, according to the report.

The Verify System is designed to allow patients to test the benefits of the Medtronic Bladder or Bowel Control Therapy prior to making a long-term commitment. Medtronic’s Bladder and Bowel Control therapies are delivered through the InterStim System.

The Verify System and InterStim System deliver mild electrical stimulation to the sacral nerves to improve bowel and bladder control, according to the report.

More articles on gastroenterology:
15 things to know about gastroenterology for ASCs
Dr. Arvind Movva: Turing to entrepreneurship to take on medication adherence
2 GI practices, 2 physicians merge to form Digestive Health Specialists: 3 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.